Dosimetric analysis of upper gastrointestinal ulcer after carbon-ion radiotherapy for pancreatic cancer

被引:32
作者
Shinoto, Makoto [1 ,2 ]
Shioyama, Yoshiyuki [1 ]
Matsunobu, Akira [1 ]
Okamoto, Kei [1 ]
Suefuji, Hiroaki [1 ]
Toyama, Shingo [1 ]
Honda, Hiroshi [2 ]
Kudo, Sho [1 ]
机构
[1] SAGA HIMAT Fdn, Ion Beam Therapy Ctr, 3049 Harakoga Machi, Tosu, Saga 8410071, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka, Japan
关键词
Pancreatic cancer; Carbon-ion radiotherapy; Dose volume histogram; Gastrointestinal ulcer; RADIATION-THERAPY; PHASE-II; GEMCITABINE; TRIAL; CHEMOTHERAPY; IRRADIATION; TOXICITY;
D O I
10.1016/j.radonc.2016.04.040
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The aim of this study was to clarify the incidence, clinical risk factors, and dose-volume relationship of upper gastrointestinal (GI) ulcer after carbon-ion radiotherapy (C-ion RT) for pancreatic cancer. Materials and methods: Fifty-eight pancreatic cancer patients were treated with C-ion RT from April 2014 to December 2015. The total dose was 55.2 Gy (RBE) in 12 fractions. D-2cm3 of GI tracts were restricted under 46 Gy (RBE); RBE-weighted absorbed dose. The association between dosimetric parameters (V10-50, D-max, D-1cm3, D-2cm3) and GI ulcer was examined using Spearman's correlation. The incidence of GI ulcer was compared between the two groups divided by the cutoff value. Results: Twelve patients (21%) experienced gastric ulcer including only one (2%) grade 3 ulcer. There was no grade 4/5 toxicity or duodenal ulcer. V10-30 was significantly associated with gastric ulcer. The 1-year estimated risk of gastric ulcer for the determined cutoff values were 51% vs. 10% (V-10, >= 102 cm(3) or less), 42% vs. 9% (V-20, >= 24 cm(3) or less), 34% vs. 4% (V-30, >= 6 cm(3) or less). Conclusions: The incidence of GI ulcer after C-ion RT was very low with the dose constraint of D-2cm3 <46 Gy (RBE). To further minimize the risk of GI ulcer, V10-30 should also be reduced. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:140 / 144
页数:5
相关论文
共 21 条
  • [1] [Anonymous], INT J RAD ONCOL BIOL
  • [2] Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer.: Definitive results of the 2000-01 FFCD/SFRO study
    Chauffert, B.
    Mornex, F.
    Bonnetain, F.
    Rougier, P.
    Mariette, C.
    Bouche, O.
    Bosset, J. F.
    Aparicio, T.
    Mineur, L.
    Azzedine, A.
    Hammel, P.
    Butel, J.
    Stremsdoerfer, N.
    Maingon, P.
    Bedenne, L.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (09) : 1592 - 1599
  • [3] LATE EFFECTS OF RADIATION-THERAPY ON THE GASTROINTESTINAL-TRACT
    COIA, LR
    MYERSON, RJ
    TEPPER, JE
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05): : 1213 - 1236
  • [4] Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer
    de Lange, SM
    van Groeningen, CJ
    Meijer, OWM
    Cuesta, MA
    Langendijk, JA
    van Riel, JMGH
    Pinedo, HM
    Peters, GJ
    Meijer, S
    Slotman, BJ
    Giaccone, G
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 (09) : 1212 - 1217
  • [5] DeLuca PM., 2007, PRESCRIBING RECORDIN
  • [6] Hammel P, 2013, J CLIN ONCOL, V31
  • [7] Dose-Volume Analysis of Predictors for Gastrointestinal Toxicity After Concurrent Full-Dose Gemcitabine and Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma
    Huang, Jiayi
    Robertson, John M.
    Ye, Hong
    Margolis, Jeffrey
    Nadeau, Laura
    Yan, Di
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (04): : 1120 - 1125
  • [8] A Multicenter Phase II Trial of S-1 With Concurrent Radiation Therapy for Locally Advanced Pancreatic Cancer
    Ikeda, Masafumi
    Ioka, Tatsuya
    Ito, Yoshinori
    Yonemoto, Naohiro
    Nagase, Michitaka
    Yamao, Kenji
    Miyakawa, Hiroyuki
    Ishii, Hiroshi
    Furuse, Junji
    Sato, Keiko
    Sato, Tosiya
    Okusaka, Takuji
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (01): : 163 - 169
  • [9] Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506
    Ishii, Hiroshi
    Furuse, Junji
    Boku, Narikazu
    Okusaka, Takuji
    Ikeda, Masafumi
    Ohkawa, Shinichi
    Fukutomi, Akira
    Hamamoto, Yasuo
    Nakamura, Kenichi
    Fukude, Haruhiko
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (06) : 573 - 579
  • [10] Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience
    Kamada, Tadashi
    Tsujii, Hirohiko
    Blakely, Eleanor A.
    Debus, Juergen
    De Neve, Wilfried
    Durante, Marco
    Jaekel, Oliver
    Mayer, Ramona
    Orecchia, Roberto
    Poetter, Richard
    Vatnitsky, Stanislav
    Chu, William T.
    [J]. LANCET ONCOLOGY, 2015, 16 (02) : E93 - E100